The present disclosure relates to, at least, a vacuum-assisted method for infiltrating cadaver bone with a cryoprotectant and a method for rapidly warming the cryopreserved cadaver bone for bone marrow processing.

Provided is a method for freezing a cell aggregate including neural cells. provided is a method for freezing a cell aggregate including neural cells and having a three-dimensional structure, which comprises following steps (1) and (2): (1) contacting a cell aggregate including neural cells and having a three-dimensional structure with a preservation solution at 0° C. to 30° C. prior to freezing to prepare a preservation solution-soaked cell aggregate; and (2) cooling the preservation solution-soaked cell aggregate obtained in step (1) from a temperature at least about 5° C. higher than the freezing point of the preservation solution to a temperature about 5° C. lower than the freezing point at an average cooling speed of 2 to 7° C./min to freeze the cell aggregate.

An agent for cryopreservation includes trehalose, HEPES and serum albumin. The agent for cryopreservation does not include potassium chloride, sodium chloride, ethylene glycol, ethylene glycol tetraacetic acid and ethylenediaminetetraacetic acid.

A straw includes a tube (11), a stopper (13) arranged in the tube and having a passage (35) extending through it, and an emptying needle (14) having a first portion (31) protruding from the stopper as far as a distal end (19) situated in the tube, and a second portion (32) situated in the passage (35) of the stopper, the needle and the stopper forming an insert (12) entirely disposed in the tube and having an internal conduit (24) fluidically connecting the internal spaces of the tube that are situated to either side of the insert, the internal conduit being formed at least in part by the needle. A method for emptying the straw includes establishing a fluidic communication between the needle and a receptacle, and making an opening in the tube in order to connect the dose of liquid-based substance to the atmosphere and allow it to flow.

The present invention provides methods for cryopreserving a population of cells with improved cell viability. In some aspects, the method comprises contacting a population of cells with a peptoid polymer comprising one or more polar peptoid monomers, e.g., formulated in a cryoprotectant solution, and cooling the population of cells at a temperature of from 0° C. to about −20° C. for a time period of at least about 3 hours to produce a population of supercooled cells. The supercooling methods of the present invention provide excellent post-thaw cell survival and recovery. In certain embodiments, the population of cells is present in a tissue or an organ that is cryopreserved by performing the supercooling methods of the present invention.

Use of glycerol in preparing an adipose tissue cryopreservation protective agent and the adipose tissue cryopreservation protective agent. Based on the total volume of the adipose tissue cryopreservation protective agent, the adipose tissue cryopreservation protective agent includes: glycerol with a volume fraction of 60-80%; 0.090-0.200 g/ml trehalose; and a PBS buffer serving as the solvent. The adipose tissue cryopreservation protective agent is free of DMSO and other protective agents having biological toxicity, poses no toxicity to cells and tissues, and causes no safety problem during clinical use even in a case of incomplete elution. The adipose tissue cryopreservation protective agent is free of xenoantigen and has low cost. With glycerol and trehalose being clinically approved medicinal ingredients and inexpensive products, the agent of the present disclosure contains no costly products such as human albumin, thus providing increased possibility for clinical use and promotion.

The subject of the invention is the use of selected polyelectrolytes from the group of synthetic and natural polyelectrolytes for the cryopreservation of human and animal extracellular vesicles. The invention also relates to a method for the cryopreservation of these vesicles, which uses said poly electrolytes.

The invention relates to a container (1) for holding a transplant object (2) and to a closure lid (4) and a vessel (3) for such a container (1). To facilitate an improved and reliable analysis and treatment of transplant objects (2), the intention being to implement particularly sparing handling, which is also protected against environmental influences, of the transplant object (2), it is proposed that the container (1) be transmissive for radiation that facilitates radiological imaging and/or a sterilization by means of ionizing radiation of the transplant object (2) held in the container (1) and that the closure lid (4) and/or the vessel (3) have one or more affixment structures (5) for fastening the transplant object (2) in the container (1). Moreover, a method and a system for providing three-dimensional structure data of a transplant object are proposed, by means of which the information obtained by the analysis is rendered better usable for medical staff. Moreover, a method and a system for sterilizing a transplant object (2) by means of ionizing radiation are described.

An anti-freezing composition according to an embodiment of the present disclosure includes at least one of a compound represented by Formula 1 and a compound represented by Formula 2. An anti-freezing composition according to another embodiment of the present disclosure includes a peptide consisting of amino acids having different chirality, thereby having an excellent effect of inhibiting ice formation or ice recrystallization.

An anti-freezing composition according to an embodiment of the present disclosure includes at least one of a compound represented by Formula 1 and a compound represented by Formula 2. An anti-freezing composition according to another embodiment of the present disclosure includes a peptide consisting of amino acids having different chirality, thereby having an excellent effect of inhibiting ice formation or ice recrystallization.